Tuesday, June 2, 2020

Strides Pharma gets USFDA nod for generic ointment to treat skin conditions

Strides Pharma gets USFDA nod for generic ointment to treat skin conditions The approval is granted to the company#39;s step-down wholly owned subsidiary, Strides Pharma Global, Singapore, by the United States Food and Drug Administration (USFDA) for triamcinolone acetonide ointment USP, 0.05 per cent, Strides Pharma Science said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/2Att3Ib
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Adani Group stocks slide up to 14% on US SEC heat

Adani Group stocks saw a sharp decline on Friday. This followed news that the US SEC is seeking court permission to email summons to founder...